1. Esakandari, H., et al., A comprehensive review of COVID-19 characteristics. Biol Proced Online, 2020. 22: p. 19.
2. Chakraborty, C., et al., SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci, 2020. 24(7): p. 4016-4026.
3. Yang, L., D. Tian, and W. Liu, [Strategies for vaccine development of COVID-19]. Sheng Wu Gong Cheng Xue Bao, 2020. 36(4): p. 593-604.
4. Younes, N., et al., Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses, 2020. 12(6).
5. Rabenau, H.F., et al., Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect, 2005. 61(2): p. 107-11.
6. Kariwa, H., N. Fujii, and I. Takashima, Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology, 2006. 212 Suppl 1: p. 119-23.
7. Zhou, P., et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020. 579(7798): p. 270-273.
8. Walls, A.C., et al., Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 2020. 181(2): p. 281-292 e6.
9. Yao, H., et al., Molecular Architecture of the SARS-CoV-2 Virus. Cell, 2020.
10. Wang, J., et al., The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech, 2020. 21(6): p. 225.
11. Totura, A.L. and S. Bavari, Broad-spectrum coronavirus antiviral drug discovery. Expert Opin Drug Discov, 2019. 14(4): p. 397-412.
12. Baghizadeh Fini, M., What dentists need to know about COVID-19. Oral Oncol, 2020. 105: p. 104741.
13. Carrouel, F., et al., Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2. J Dent Res, 2021. 100(2): p. 124-132.
14. Seneviratne, C.J., et al., Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore. Infection, 2020.
15. Vergara-Buenaventura, A. and C. Castro-Ruiz, Use of mouthwashes against COVID-19 in dentistry. Br J Oral Maxillofac Surg, 2020. 58(8): p. 924-927.
16. Seo, H.W., et al., Cetylpyridinium chloride interaction with the hepatitis B virus core protein inhibits capsid assembly. Virus Res, 2019. 263: p. 102-111.
17. Miranda, S.L.F., et al., In Vitro Antimicrobial Effect of Cetylpyridinium Chloride on Complex Multispecies Subgingival Biofilm. Braz Dent J, 2020. 31(2): p. 103-108.
18. Baker, N., et al., Repurposing Quaternary Ammonium Compounds as Potential Treatments for COVID-19. Pharm Res, 2020. 37(6): p. 104.
19. Ramakrishnan, M.A., Determination of 50% endpoint titer using a simple formula. World J Virol, 2016. 5(2): p. 85-6.